Stocksigma LogoStocksigma Logo

Bafna Pharmaceuticals Schedules Board Meeting to Approve Q2 FY27 Results

Bafna Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 11th Nov'26 to consider and approve the un-audited financial results for

Bafna Pharmaceuticals Schedules Board Meeting to Approve Q2 FY27 Results

Bafna Pharmaceuticals Ltd 路 Intimation 路 11 Nov 2026, 5:30 am

Bafna Pharmaceuticals Schedules Board Meeting to Approve Q2 FY27 Results Bafna Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 11th Nov'26 to consider and approve the un-audited financial results for the quarter and half-year ended 30th Sep'26. Additionally, in compliance with insider trading regulations, the trading window for dealing in company shares by designated persons and their immediate relatives remains closed from 1st Oct'26 to 13th Nov'26 (both days inclusive).

Original exchange filing (PDF)

More announcements from Bafna Pharmaceuticals Ltd

All Bafna Pharmaceuticals Ltd announcements